ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,979.25
      -0.10%
      US Tech 100
      20,438.40
      -0.25%
      Dow Jones
      43,958.79
      0.00%
      Brent Oil
      72.485
      0.86%
      Bitcoin
      87,797.30
      -3.06%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aquestive Therapeutics Inc (AQST)

      7. Aquestive Therapeutics Inc (AQST) Financials

      Aquestive Therapeutics Inc

      Aquestive Therapeutics Inc (AQST)

      NASDAQ
      4.755
      -0.075
      ( -1.55% )
      Updated: 10:59:58
      Delayed by 15 minutes

      Aquestive Therapeutics Inc Financial Summary

      The current AQST market cap is 433.55M. The company's latest EPS is USD -0.0863 and P/E is -55.16.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 13.24M13M13.21M12.05M20.1M
      Operating Income -4.21M-2.38M-3.91M-8.96M55k
      Net Income -5.79M-2.04M-8.11M-12.83M-2.75M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 52.61M45.85M50.83M47.68M50.58M
      Operating Income -52.67M-42.89M-34.68M-42.07M-15.1M
      Net Income -66.25M-55.78M-70.54M-54.41M-7.87M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 56.99M59.45M57.42M129.52M117.61M
      Total Liabilities 163.65M162.38M163.91M165.82M153.08M
      Total Equity -106.65M-102.93M-106.49M-36.3M-35.48M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 78.48M62.88M61.99M57.07M57.42M
      Total Liabilities 84.6M111.38M144.13M175.62M163.91M
      Total Equity -6.12M-48.5M-82.13M-118.55M-106.49M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 909k-1.44M-6.38M-10.38M-17.39M
      Investing -828k-979k-995k-29k-64k
      Financing -17.46M61k3.97M81.74M83.45M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -60.21M-45.46M-32.98M-9.79M-6.38M
      Investing -663k-517k-913k-2.52M-995k
      Financing 49.6M28.46M30.11M11.56M3.97M

      Stats and Ratios

      Market Cap 433.55M
      Price to Earnings Ratio -55.16
      Price to Sales Ratio 8.58
      Price to Cash Ratio 18.18
      Price to Book Ratio -4.08
      Dividend Yield -

      Share Statistics

      Shares Outstanding 91.18M
      Average Volume (1 week) 1.62M
      Average Volume (1 Month) 1.63M
      52 Week Change 176.45%
      52 Week High 6.23
      52 Week Low 1.55
      Spread (Intraday) 0.01 (0.21%)

      Company Info

      Company Name Aquestive Therapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.aquestive.com
      Industry pharmaceutical preparations (2834)